Journal of Global Infectious DiseasesOfficial Publishing of INDUSEM and OPUS 12 Foundation, Inc. Users online:81  
Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size     
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
 

    Article Cited by others

SYMPOSIUM

Fundamentals of vaccine immunology

Clem Angela S

Year : 2011| Volume: 3| Issue : 1 | Page no: 73-78

   This article has been cited by
 
1 The search for a Buruli Ulcer vaccine and the effectiveness of the Bacillus Calmette–Guérin vaccine
Tamara Z. Ishwarlall, Moses Okpeku, Adebayo A Adeniyi, Matthew A. Adeleke
Acta Tropica. 2022; : 106323
[Pubmed]  [Google Scholar] [DOI]
2 Toward rational vaccine engineering
Yashavantha L. Vishweshwaraiah, Nikolay V. Dokholyan
Advanced Drug Delivery Reviews. 2022; 183: 114142
[Pubmed]  [Google Scholar] [DOI]
3 Dendritic cell activation by a micro particulate based system containing the influenza matrix-2 protein virus-like particle (M2e VLP)
Kimberly Braz Gomes, Grace Lovia Allotey-Babington, Sucheta D'Sa, Sang-Moo Kang, Martin J. D'Souza
International Journal of Pharmaceutics. 2022; : 121667
[Pubmed]  [Google Scholar] [DOI]
4 Mechanisms underpinning poor antibody responses to vaccines in ageing
Jia Le Lee, Michelle A Linterman
Immunology Letters. 2022; 241: 1
[Pubmed]  [Google Scholar] [DOI]
5 Mucosal immune responses to infection and vaccination in the respiratory tract
Robert C. Mettelman, E. Kaitlynn Allen, Paul G. Thomas
Immunity. 2022; 55(5): 749
[Pubmed]  [Google Scholar] [DOI]
6 Quantitative and qualitative features of acute phase-adverse events following SARS-CoV-2 vaccination in a large sample of people with multiple sclerosis
E. Tavazzi, G. Della Porta, F.S. Robustelli della Cuna, L. Gervasio, E. Guerra, M.A. Tejada Condemayta, A. Filosa, C. Montomoli, R. Bergamaschi
Multiple Sclerosis and Related Disorders. 2022; 68: 104120
[Pubmed]  [Google Scholar] [DOI]
7 Characterization of Prostanoids Response to Bordetella pertussis Antigen BscF and Tdap in LPS-challenged monocytes
Md. Obayed Raihan, Brenna M. Espelien, Courtney Hanson, Brett A. McGregor, Nathan A. Velaris, Travis D. Alvine, Svetlana Al Golovko, David S. Bradley, Matthew Nilles, Mikhail Y. Glovko, Junguk Hur, James E. Porter
Prostaglandins, Leukotrienes and Essential Fatty Acids. 2022; : 102452
[Pubmed]  [Google Scholar] [DOI]
8 Enhancement of live vaccines by co-delivery of immune modulating proteins
Megha M. Manohar, Bronwyn E. Campbell, Anna K. Walduck, Robert J. Moore
Vaccine. 2022;
[Pubmed]  [Google Scholar] [DOI]
9 COVID-19 Vaccines: Update of the vaccines in use and under development
Rafaela Angotti Marta, Gisele Emy Kondo Nakamura, Bruno de Matos Aquino, Paulo R. Bignardi
Vacunas. 2022;
[Pubmed]  [Google Scholar] [DOI]
10 Variant-specific vaccination induces systems immune responses and potent in vivo protection against SARS-CoV-2
Lei Peng, Paul A. Renauer, Arya Ökten, Zhenhao Fang, Jonathan J. Park, Xiaoyu Zhou, Qianqian Lin, Matthew B. Dong, Renata Filler, Qiancheng Xiong, Paul Clark, Chenxiang Lin, Craig B. Wilen, Sidi Chen
Cell Reports Medicine. 2022; 3(5): 100634
[Pubmed]  [Google Scholar] [DOI]
11 T helper type (Th1/Th2) responses to SARS-CoV-2 and influenza A (H1N1) virus: From cytokines produced to immune responses
Elahe Aleebrahim-Dehkordi, Bahareh Molavi, Melika Mokhtari, Niloofar Deravi, Mobina Fathi, Tara Fazel, Mehdi Mohebalizadeh, Pooneh Koochaki, Parnian Shobeiri, Ali Hasanpour-Dehkordi
Transplant Immunology. 2022; 70: 101495
[Pubmed]  [Google Scholar] [DOI]
12 Designing ferritin nanocage based vaccine candidates for SARS-CoV-2 by in silico engineering of its HLA I and HLA II epitope peptides
Pratibha Manickavasagam, Suman Abhishek, Eerappa Rajakumara
Journal of Biomolecular Structure and Dynamics. 2022; : 1
[Pubmed]  [Google Scholar] [DOI]
13 Is Hepatitis-B Immunization Effective During Chronic Liver Fibrosis? Investigation of Secretory and Cellular Immune Responses on an Experimental Model
Basak Kayhan, Zeynal Mete Karaca, Esra Canpolat, Veysel Ersan, Mehmet Gül, Saim Yologolu, Sezai Yilmaz
Immunopharmacology and Immunotoxicology. 2022; : 1
[Pubmed]  [Google Scholar] [DOI]
14 Dendritic cell-based vaccine: the state-of-the-art vaccine platform for COVID-19 management
Vivek P. Chavda, Aayushi B. Patel, Lalitkumar K. Vora, Vasso Apostolopoulos, Bruce D. Uhal
Expert Review of Vaccines. 2022; : 1
[Pubmed]  [Google Scholar] [DOI]
15 The anti-SARS-CoV-2 monoclonal antibody, bamlanivimab, minimally impacts the endogenous immune response to COVID-19 vaccination
Robert J. Benschop, Jay L. Tuttle, Lin Zhang, Josh Poorbaugh, Nicole L. Kallewaard, Peter Vaillancourt, Melissa Crisp, Thi Ngoc Vy Trinh, Joshua J. Freitas, Stephanie Beasley, Montanea Daniels, Natalie Haustrup, Richard E. Higgs, Ajay Nirula, Myron S. Cohen, Mary Marovich
Science Translational Medicine. 2022;
[Pubmed]  [Google Scholar] [DOI]
16 Methotrexate Treatment Suppresses Monocytes in Nonresponders to Pneumococcal Conjugate Vaccine in Rheumatoid Arthritis Patients
Evelina Elmér, Per Nived, Åsa Pettersson, Lillemor Skattum, Thomas Hellmark, Meliha C. Kapetanovic, Åsa C. M. Johansson, Dawei Cui
Journal of Immunology Research. 2022; 2022: 1
[Pubmed]  [Google Scholar] [DOI]
17 Application of microneedle patches for drug delivery; doorstep to novel therapies
Fateme Nazary Abrbekoh, Leila Salimi, Sepideh Saghati, Hassan Amini, Sonia Fathi Karkan, Keyvan Moharamzadeh, Emel Sokullu, Reza Rahbarghazi
Journal of Tissue Engineering. 2022; 13: 2041731422
[Pubmed]  [Google Scholar] [DOI]
18 Response to SARS-CoV-2 vaccines in patients receiving B-cell modulating antibodies for renal autoimmune disease
Frederic Arnold, Daniela Huzly, Yakup Tanriver, Thomas Welte
BMC Infectious Diseases. 2022; 22(1)
[Pubmed]  [Google Scholar] [DOI]
19 COVID-19 vaccination in Nigeria: A rapid review of vaccine acceptance rate and the associated factors
Oluwatosin Olu-Abiodun, Olumide Abiodun, Ngozi Okafor, Nusirat Elelu
PLOS ONE. 2022; 17(5): e0267691
[Pubmed]  [Google Scholar] [DOI]
20 Differences in B-Cell Immunophenotypes and Neutralizing Antibodies Against SARS-CoV-2 After Administration of BNT162b2 (Pfizer-BioNTech) Vaccine in Individuals with and without Prior COVID-19 - A Prospective Cohort Study
José Javier Morales-Núñez, Mariel García-Chagollán, José Francisco Muñoz-Valle, Saúl Alberto Díaz-Pérez, Paola Carolina Torres-Hernández, Saraí Citlalic Rodríguez-Reyes, Guillermo Santoscoy-Ascencio, José Julio Sierra García de Quevedo, Jorge Hernández-Bello
Journal of Inflammation Research. 2022; Volume 15: 4449
[Pubmed]  [Google Scholar] [DOI]
21 Local and Systemic Immunity Are Impaired in End-Stage-Renal-Disease Patients Treated With Hemodialysis, Peritoneal Dialysis and Kidney Transplant Recipients Immunized With BNT162b2 Pfizer-BioNTech SARS-CoV-2 Vaccine
Magdalena Piotrowska, Maciej Zielinski, Leszek Tylicki, Bogdan Biedunkiewicz, Alicja Kubanek, Zuzanna Slizien, Karolina Polewska, Piotr Tylicki, Marta Muchlado, Justyna Sakowska, Marcin Renke, Adam Sudol, Malgorzata Dabrowska, Monika Lichodziejewska-Niemierko, Tomasz Smiatacz, Alicja Debska-Slizien, Piotr Trzonkowski
Frontiers in Immunology. 2022; 13
[Pubmed]  [Google Scholar] [DOI]
22 Editorial: Research, Development and Clinical Trials for Peptide-Based Vaccines
Shisong Jiang, Min Gong, Xiao-Ning Xu
Frontiers in Immunology. 2022; 13
[Pubmed]  [Google Scholar] [DOI]
23 Acute Vertigo After COVID-19 Vaccination: Case Series and Literature Review
Paola Di Mauro, Ignazio La Mantia, Salvatore Cocuzza, Pasqua Irene Sciancalepore, Deborak Rasà, Antonino Maniaci, Salvatore Ferlito, Isabella Tundo, Roberta Anzivino
Frontiers in Medicine. 2022; 8
[Pubmed]  [Google Scholar] [DOI]
24 Acute Unilateral Peripheral Vestibulopathy After COVID-19 Vaccination: Initial Experience in a Tertiary Neurotology Center
Marc Basil Schmid, David Bächinger, Athina Pangalu, Dominik Straumann, Julia Dlugaiczyk
Frontiers in Neurology. 2022; 13
[Pubmed]  [Google Scholar] [DOI]
25 Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC
Rachel Evans, Kelvin Lee, Paul K. Wallace, Mary Reid, Jason Muhitch, Askia Dozier, Circe Mesa, Patricia L. Luaces, Orestes Santos-Morales, Adrienne Groman, Carlos Cedeno, Aileen Cinquino, Daniel T. Fisher, Igor Puzanov, Mateusz Opyrchal, Christos Fountzilas, Tong Dai, Marc Ernstoff, Kristopher Attwood, Alan Hutson, Candace Johnson, Zaima Mazorra, Danay Saavedra, Kalet Leon, Agustin Lage, Tania Crombet, Grace K. Dy
Frontiers in Oncology. 2022; 12
[Pubmed]  [Google Scholar] [DOI]
26 Audiovestibular Disorders after COVID-19 Vaccine: Is There an Association?
Davide Pisani, Federico Maria Gioacchini, Pasquale Viola, Alfonso Scarpa, Alessia Astorina, Massimo Re, Gianmarco Marcianò, Francesco Manti, Roberta Anzivino, Giuseppe Chiarella
Audiology Research. 2022; 12(3): 212
[Pubmed]  [Google Scholar] [DOI]
27 Comparative Reverse Vaccinology of Piscirickettsia salmonis, Aeromonas salmonicida, Yersinia ruckeri, Vibrio anguillarum and Moritella viscosa, Frequent Pathogens of Atlantic Salmon and Lumpfish Aquaculture
Joy Chukwu-Osazuwa, Trung Cao, Ignacio Vasquez, Hajarooba Gnanagobal, Ahmed Hossain, Vimbai Irene Machimbirike, Javier Santander
Vaccines. 2022; 10(3): 473
[Pubmed]  [Google Scholar] [DOI]
28 Immunoinformatics and Biophysics Approaches to Design a Novel Multi-Epitopes Vaccine Design against Staphylococcus auricularis
Roba Attar, Eid A. Alatawi, Faris F. Aba Alkhayl, Khloud Nawaf Alharbi, Khaled S. Allemailem, Ahmad Almatroudi
Vaccines. 2022; 10(5): 637
[Pubmed]  [Google Scholar] [DOI]
29 An In-Silico Investigation to Design a Multi-Epitopes Vaccine against Multi-Drug Resistant Hafnia alvei
Fahad M. Alshabrmi, Faris Alrumaihi, Sahar Falah Alrasheedi, Wafa Abdullah I. Al-Megrin, Ahmad Almatroudi, Khaled S. Allemailem
Vaccines. 2022; 10(7): 1127
[Pubmed]  [Google Scholar] [DOI]
30 Microneedle Delivery of an Adjuvanted Microparticulate Vaccine Induces High Antibody Levels in Mice Vaccinated against Coronavirus
Sharon Vijayanand, Smital Patil, Devyani Joshi, Ipshita Menon, Keegan Braz Gomes, Akanksha Kale, Priyal Bagwe, Shadi Yacoub, Mohammad N. Uddin, Martin J. D’Souza
Vaccines. 2022; 10(9): 1491
[Pubmed]  [Google Scholar] [DOI]
31 Possible Correlations between the COVID-19 mRNA Vaccine and Contracting Myocarditis/Pericarditis in Young Adults
Carl Dowling
Journal of Biomedical Research & Environmental Sciences. 2022; 3(4): 453
[Pubmed]  [Google Scholar] [DOI]
32 Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19?
Abdul Hawil Abas, Siti Marfuah, Rinaldi Idroes, Diah Kusumawaty, Fatimawali, Moon Nyeo Park, Abolghasem Siyadatpanah, Fahad A. Alhumaydhi, Shafi Mahmud, Trina Ekawati Tallei, Talha Bin Emran, Bonglee Kim
Molecules. 2022; 27(7): 2221
[Pubmed]  [Google Scholar] [DOI]
33 Introducing B Cell Epitopes of Newcastle Disease Virus Obtained from Domestic Pigeons (Columba livia domestica) as Sub-Unit Vaccine Candidate to Eradicate Newcastle Disease Virus in Poultry
Jola Rahmahani, Tetri Regilya Fatimah, Anastasia Hanny Irawan, Naimah Putri, Eryk Hendrianto, Fedik Abdul Rantam
Research Journal of Pharmacy and Technology. 2022; : 2059
[Pubmed]  [Google Scholar] [DOI]
34 Vaccinations in patients with multiple sclerosis: review and recommendations
Cassie Nesbitt, Louise Rath, Michael Zhong, Allen C Cheng, Helmut Butzkueven, Robb Wesselingh, Olga Skibina, Mastura Monif, Wei Yeh, Julia ML Brotherton, Stephen Reddel, Anneke Van Der Walt
Medical Journal of Australia. 2021; 214(8): 350
[Pubmed]  [Google Scholar] [DOI]
35 COVID-19 Vaccine: Critical Questions with Complicated Answers
Mohammad Faisal Haidere, Zubair Ahmed Ratan, Senjuti Nowroz, Sojib Bin Zaman, You-Jung Jung, Hassan Hosseinzadeh, Jae Youl Cho
Biomolecules & Therapeutics. 2021; 29(1): 1
[Pubmed]  [Google Scholar] [DOI]
36 Vaccine in response to COVID-19: Recent developments, challenges, and a way out
Sameer Quazi
Biomedical and Biotechnology Research Journal (BBRJ). 2021; 5(2): 105
[Pubmed]  [Google Scholar] [DOI]
37 COVID-19 vaccines: A ray of hope
Neha Chand, Rajani Mathur, Shridhar Dwivedi
Indian Journal of Medical Specialities. 2021; 12(4): 188
[Pubmed]  [Google Scholar] [DOI]
38 A comprehensive insight on the COVID-19 vaccine candidates
Anu Sharma, RaviPrakash Sharma, Rimplejeet Kaur, Ria Sharma, Surjit Singh
Journal of Family Medicine and Primary Care. 2021; 10(7): 2457
[Pubmed]  [Google Scholar] [DOI]
39 Development of Fish Parasite Vaccines in the OMICs Era: Progress and Opportunities
Saloni Shivam, Mansour El-Matbouli, Gokhlesh Kumar
Vaccines. 2021; 9(2): 179
[Pubmed]  [Google Scholar] [DOI]
40 Chemical Conjugation Strategies for the Development of Protein-Based Subunit Nanovaccines
Lantian Lu, Viet Tram Duong, Ahmed O. Shalash, Mariusz Skwarczynski, Istvan Toth
Vaccines. 2021; 9(6): 563
[Pubmed]  [Google Scholar] [DOI]
41 Analysis of Host Immunological Response of Adenovirus-Based COVID-19 Vaccines
Suzan Farhang-Sardroodi, Chapin S. Korosec, Samaneh Gholami, Morgan Craig, Iain R. Moyles, Mohammad Sajjad Ghaemi, Hsu Kiang Ooi, Jane M. Heffernan
Vaccines. 2021; 9(8): 861
[Pubmed]  [Google Scholar] [DOI]
42 Recombinant Antigen of Type 2 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV-2) Promotes M1 Repolarization of Porcine Alveolar Macrophages and Th1 Type Response
Rika Wahyuningtyas, Yin-Siew Lai, Mei-Li Wu, Hsin-Wei Chen, Wen-Bin Chung, Hso-Chi Chaung, Ko-Tung Chang
Vaccines. 2021; 9(9): 1009
[Pubmed]  [Google Scholar] [DOI]
43 COVID-19 Vaccine Platforms: Challenges and Safety Contemplations
Hadeel T. Al-Jighefee, Hoda Najjar, Muna Nizar Ahmed, Abeer Qush, Sara Awwad, Layla Kamareddine
Vaccines. 2021; 9(10): 1196
[Pubmed]  [Google Scholar] [DOI]
44 A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues
Shahad Saif Khandker, Brian Godman, Md. Irfan Jawad, Bushra Ayat Meghla, Taslima Akter Tisha, Mohib Ullah Khondoker, Md. Ahsanul Haq, Jaykaran Charan, Ali Azam Talukder, Nafisa Azmuda, Shahana Sharmin, Mohd. Raeed Jamiruddin, Mainul Haque, Nihad Adnan
Vaccines. 2021; 9(12): 1387
[Pubmed]  [Google Scholar] [DOI]
45 A Review of UK-Registered and Candidate Vaccines for Bovine Respiratory Disease
Joanne L. Lemon, Michael J. McMenamy
Vaccines. 2021; 9(12): 1403
[Pubmed]  [Google Scholar] [DOI]
46 Update on the Inactivation Procedures for the Vaccine Development Prospects of a New Highly Virulent RGNNV Isolate
Alberto Falco, Melissa Bello-Perez, Rocío Díaz-Puertas, Matthew Mold, Mikolaj Adamek
Vaccines. 2021; 9(12): 1441
[Pubmed]  [Google Scholar] [DOI]
47 Factor Influences for Diagnosis and Vaccination of Avian Infectious Bronchitis Virus (Gammacoronavirus) in Chickens
Md. Safiul Alam Bhuiyan, Zarina Amin, Ag Muhammad Sagaf Abu Bakar, Suryani Saallah, Noor Hydayaty Md. Yusuf, Sharifudin Md. Shaarani, Shafiquzzaman Siddiquee
Veterinary Sciences. 2021; 8(3): 47
[Pubmed]  [Google Scholar] [DOI]
48 Immune responses induced by different vaccine platforms against coronavirus disease-19
Eknath D. Ahire, Sanjay J Kshirsagar
Exploration of Immunology. 2021; : 243
[Pubmed]  [Google Scholar] [DOI]
49 COVID-19 Vaccines: Current Conditions and Future Prospects
Tarek Zieneldien, Janice Kim, Jessica Cao, Chuanhai Cao
Biology. 2021; 10(10): 960
[Pubmed]  [Google Scholar] [DOI]
50 Remission-Stage Ovarian Cancer Cell Vaccine with Cowpea Mosaic Virus Adjuvant Prevents Tumor Growth
Courtney T. Stump, Gregory Ho, Chenkai Mao, Frank A. Veliz, Veronique Beiss, Jennifer Fields, Nicole F. Steinmetz, Steven Fiering
Cancers. 2021; 13(4): 627
[Pubmed]  [Google Scholar] [DOI]
51 Recent Development of Ruminant Vaccine Against Viral Diseases
Sk Mohiuddin Choudhury, XuSheng Ma, Wen Dang, YuanYuan Li, HaiXue Zheng
Frontiers in Veterinary Science. 2021; 8
[Pubmed]  [Google Scholar] [DOI]
52 Tailored Nanoparticles as Vaccine Components
Alina Popa, Sebastian Springer
Applied Sciences. 2021; 11(24): 11898
[Pubmed]  [Google Scholar] [DOI]
53 What Could Explain the Lower COVID-19 Burden in Africa despite Considerable Circulation of the SARS-CoV-2 Virus?
Richard G. Wamai, Jason L. Hirsch, Wim Van Damme, David Alnwick, Robert C. Bailey, Stephen Hodgins, Uzma Alam, Mamka Anyona
International Journal of Environmental Research and Public Health. 2021; 18(16): 8638
[Pubmed]  [Google Scholar] [DOI]
54 Current Immunological and Clinical Perspective on Vaccinations in Multiple Sclerosis Patients: Are They Safe after All?
Shani Witman Tsur, Eli Adrian Zaher, Meydan Tsur, Karolina Kania, Alicja Kalinowska-Lyszczarz
International Journal of Molecular Sciences. 2021; 22(8): 3859
[Pubmed]  [Google Scholar] [DOI]
55 COVID-19: Insights into Potential Vaccines
Ke-Yan Loo, Vengadesh Letchumanan, Hooi-Leng Ser, Siew Li Teoh, Jodi Woan-Fei Law, Loh Teng-Hern Tan, Nurul-Syakima Ab Mutalib, Kok-Gan Chan, Learn-Han Lee
Microorganisms. 2021; 9(3): 605
[Pubmed]  [Google Scholar] [DOI]
56 Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines
Alexander J. Stephens, Nicola A. Burgess-Brown, Shisong Jiang
Frontiers in Immunology. 2021; 12
[Pubmed]  [Google Scholar] [DOI]
57 Hijacking of the Host’s Immune Surveillance Radars by Burkholderia pseudomallei
Vanitha Mariappan, Kumutha Malar Vellasamy, Muttiah Barathan, A. S. Smiline Girija, Esaki M. Shankar, Jamuna Vadivelu
Frontiers in Immunology. 2021; 12
[Pubmed]  [Google Scholar] [DOI]
58 Molecular and Clinical Aspects of COVID-19 Vaccines and Other Therapeutic Interventions Apropos Emerging Variants of Concern
Khursheed Ul Islam, Thoraya Mohamed Elhassan A-Elgadir, Sarah Afaq, Tanveer Ahmad, Jawed Iqbal
Frontiers in Pharmacology. 2021; 12
[Pubmed]  [Google Scholar] [DOI]
59 The Development of mRNA Vaccines for Infectious Diseases: Recent Updates
Nitika, Jiao Wei, Ai-Min Hui
Infection and Drug Resistance. 2021; Volume 14: 5271
[Pubmed]  [Google Scholar] [DOI]
60 Knowledge and Attitudes of Young Adults Towards Donation of COVID-19 Convalescent Plasma and Its Therapeutic Properties
Lidia Perenc, Ryszard Peczkowski
Journal of Blood Medicine. 2021; Volume 12: 709
[Pubmed]  [Google Scholar] [DOI]
61 The PentaFOLD 3.0 Algorithm for the Selection of Stable Elements of Secondary Structure to be Included in Vaccine Peptides
Vladislav V. Khrustalev
Protein & Peptide Letters. 2021; 28(5): 573
[Pubmed]  [Google Scholar] [DOI]
62 An Updated Overview of Herpes Simplex Virus-1 Infection: Insights from Origin to Mitigation Measures
Abu Tayab Moin, Mohammad Al-baruni Chowdhury, Sumaiya Hafiz Riana, Md. Asad Ullah, Yusha Araf, Bishajit Sarkar, Abdullah Mohammad Shohael
Electronic Journal of General Medicine. 2021; 18(4): em299
[Pubmed]  [Google Scholar] [DOI]
63 AN OVERVIEW OF SUBUNIT-BASED VACCINES FOR PULMONARY ADMINISTRATION
Melike ONGUN, Basaran MUTLU-AGARDAN, Fusun ACARTURK
Ankara Universitesi Eczacilik Fakultesi Dergisi. 2021; : 109
[Pubmed]  [Google Scholar] [DOI]
64 Influence of chronic hepatitis C infection on the monocyte-to-platelet ratio: data analysis from the National Health and Nutrition Examination Survey (2009–2016)
Aidan M. Nikiforuk, Mohammad Ehsanul Karim, David M. Patrick, Agatha N. Jassem
BMC Public Health. 2021; 21(1)
[Pubmed]  [Google Scholar] [DOI]
65 Comprehensive literature review on COVID-19 vaccines and role of SARS-CoV-2 variants in the pandemic
Charles Yap, Abulhassan Ali, Amogh Prabhakar, Akul Prabhakar, Aman Pal, Ying Yi Lim, Pramath Kakodkar
Therapeutic Advances in Vaccines and Immunotherapy. 2021; 9: 2515135521
[Pubmed]  [Google Scholar] [DOI]
66 Racing to immunity: Journey to a COVID-19 vaccine and lessons for the future
Ester Calvo Fernández, Lucie Y. Zhu
British Journal of Clinical Pharmacology. 2021; 87(9): 3408
[Pubmed]  [Google Scholar] [DOI]
67 A guide to investigating immune responses elicited by whole-sporozoite pre-erythrocytic vaccines against malaria
Diana Moita, Helena Nunes-Cabaço, António M. Mendes, Miguel Prudêncio
The FEBS Journal. 2021;
[Pubmed]  [Google Scholar] [DOI]
68 Zebrafish Embryos Immune System induction with BSA as an initial Screening model for Covid-19 Treatment
Dita Arya Widatama, Bambang Retnoaji
IOP Conference Series: Earth and Environmental Science. 2021; 755(1): 012012
[Pubmed]  [Google Scholar] [DOI]
69 Oral Polio Vaccine to Protect Against COVID-19: Out of the Box Strategies?
Melanie Malave Sanchez, Paul Saleeb, Shyam Kottilil, Poonam Mathur
Open Forum Infectious Diseases. 2021; 8(8)
[Pubmed]  [Google Scholar] [DOI]
70 Otologic Manifestations After COVID-19 Vaccination: The House Ear Clinic Experience
Helena Wichova, Mia E. Miller, M. Jennifer Derebery
Otology & Neurotology. 2021; 42(9): e1213
[Pubmed]  [Google Scholar] [DOI]
71 Non-specific effects of veterinary vaccines: a systematic review
Sintayehu M. Arega, Darryn L. Knobel, Felix N. Toka, Anne Conan
Vaccine. 2021;
[Pubmed]  [Google Scholar] [DOI]
72 Designing a multi-epitope vaccine against Mycobacteroides abscessus by pangenome-reverse vaccinology
Hamza Arshad Dar, Saba Ismail, Yasir Waheed, Sajjad Ahmad, Zubia Jamil, Hafsa Aziz, Helal F. Hetta, Khalid Muhammad
Scientific Reports. 2021; 11(1)
[Pubmed]  [Google Scholar] [DOI]
73 A comprehensive overview of vaccines developed for pandemic viral pathogens over the past two decades including those in clinical trials for the current novel SARS-CoV-2
Kannan Damodharan, Gandarvakottai Senthilkumar Arumugam, Suresh Ganesan, Mukesh Doble, Sathiah Thennarasu
RSC Advances. 2021; 11(33): 20006
[Pubmed]  [Google Scholar] [DOI]
74 Vaccination Update for Nurse Practitioners Caring for Adults
Patrick C. Crane
Advances in Family Practice Nursing. 2021; 3: 15
[Pubmed]  [Google Scholar] [DOI]
75 Positive affect and peripheral inflammatory markers among adults: A narrative review
Dusti R. Jones, Jennifer E. Graham-Engeland
Psychoneuroendocrinology. 2021; 123: 104892
[Pubmed]  [Google Scholar] [DOI]
76 Early-life exposure to widespread environmental toxicants and children's health risks: A focus on the post-vaccination antibody potency or immunoglobulin levels
Zhijun Zeng, Sieglind Ngai, Qihua Wang, Wanting Liang, Xia Huo
Science of The Total Environment. 2021; 781: 146714
[Pubmed]  [Google Scholar] [DOI]
77 Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity
Hylemariam Mihiretie Mengist, Arnaud John Kombe Kombe, Daniel Mekonnen, Abtie Abebaw, Melese Getachew, Tengchuan Jin
Seminars in Immunology. 2021; : 101533
[Pubmed]  [Google Scholar] [DOI]
78 Brain Tumor Vaccines
Justin Lee, Benjamin R. Uy, Linda M. Liau
Neurosurgery Clinics of North America. 2021; 32(2): 225
[Pubmed]  [Google Scholar] [DOI]
79 B cell therapy and the use of RNA-based COVID-19 vaccines
Anastasia Vishnevetsky, Chris Hawkes, Jeannette Lechner-Scott, Gavin Giovannoni, Michael Levy, Daniela Pohl
Multiple Sclerosis and Related Disorders. 2021; 49: 102887
[Pubmed]  [Google Scholar] [DOI]
80 In silico CD4+ T-cell multiepitope prediction and HLA distribution analysis for Marburg Virus—A strategy for vaccine designing
Anupam Dhasmana, Swati Dhasmana, Ahmad Alsulimani, Sudhir Kotnala, Vivek Kumar Kashyap, Shafiul Haque, Meena Jaggi, Murali M. Yallapu, Subhash C. Chauhan
Journal of King Saud University - Science. 2021; : 101751
[Pubmed]  [Google Scholar] [DOI]
81 Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients
Hannah Kelly, Brent Sokola, Hesham Abboud
Journal of Neuroimmunology. 2021; 356: 577599
[Pubmed]  [Google Scholar] [DOI]
82 Various theranostics and immunization strategies based on nanotechnology against Covid-19 pandemic: An interdisciplinary view
Sujan Chatterjee, Snehasis Mishra, Kaustav Dutta Chowdhury, Chandan Kumar Ghosh, Krishna Das Saha
Life Sciences. 2021; 278: 119580
[Pubmed]  [Google Scholar] [DOI]
83 Nanocarrier vaccines for SARS-CoV-2
Jatin Machhi, Farah Shahjin, Srijanee Das, Milankumar Patel, Mai Mohamed Abdelmoaty, Jacob D. Cohen, Preet Amol Singh, Ashish Baldi, Neha Bajwa, Raj Kumar, Lalit K. Vora, Tapan A. Patel, Maxim D. Oleynikov, Dhruvkumar Soni, Pravin Yeapuri, Insiya Mukadam, Rajashree Chakraborty, Caroline G. Saksena, Jonathan Herskovitz, Mahmudul Hasan, David Oupicky, Suvarthi Das, Ryan F. Donnelly, Kenneth S. Hettie, Linda Chang, Howard E. Gendelman, Bhavesh D. Kevadiya
Advanced Drug Delivery Reviews. 2021; 171: 215
[Pubmed]  [Google Scholar] [DOI]
84 Vaccine delivery systems toward lymph nodes
Yingyue Ding, Zhaoting Li, Ana Jaklenec, Quanyin Hu
Advanced Drug Delivery Reviews. 2021; : 113914
[Pubmed]  [Google Scholar] [DOI]
85 Biomaterials and nanomaterials for sustained release vaccine delivery
Michael A. Luzuriaga, Arezoo Shahrivarkevishahi, Fabian C. Herbert, Yalini H. Wijesundara, Jeremiah J. Gassensmith
WIREs Nanomedicine and Nanobiotechnology. 2021; 13(6)
[Pubmed]  [Google Scholar] [DOI]
86 Nanoscience versus Viruses: The SARS-CoV-2 Case
Joanna Goscianska, Ralph Freund, Stefan Wuttke
Advanced Functional Materials. 2021; : 2107826
[Pubmed]  [Google Scholar] [DOI]
87 Enhancement of immunopotentiation using tetanus toxoid-based nanoparticulate dissolvable microneedles
Mansi Waghchaure, Sharayu Govardhane, Pravin Shende
Biomedical Microdevices. 2021; 23(3)
[Pubmed]  [Google Scholar] [DOI]
88 Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era
Patricia K. Coyle, Anne Gocke, Megan Vignos, Scott D. Newsome
Advances in Therapy. 2021; 38(7): 3550
[Pubmed]  [Google Scholar] [DOI]
89 COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment
Shaghayegh Sadeghmousavi, Nima Rezaei
SN Comprehensive Clinical Medicine. 2020; 2(10): 1802
[Pubmed]  [Google Scholar] [DOI]
90 Coronavirus Disease 2019 (COVID-19) Spread and Pharmacovigilance Implications: Expert Opinion
Peter Yamoah, Thelma Mpoku Alalbila, Varsha Bangalee, Frasia Oosthuizen
Therapeutic Innovation & Regulatory Science. 2020; 54(6): 1359
[Pubmed]  [Google Scholar] [DOI]
91 Stimuli-Responsive Biomaterials for Vaccines and Immunotherapeutic Applications
Noah Pacifici, Amir Bolandparvaz, Jamal S. Lewis
Advanced Therapeutics. 2020; 3(11): 2000129
[Pubmed]  [Google Scholar] [DOI]
92 Incorporation of a Novel CD4+ Helper Epitope Identified from Aquifex aeolicus Enhances Humoral Responses Induced by DNA and Protein Vaccinations
Ziyang Xu, Neethu Chokkalingam, Edgar Tello-Ruiz, Susanne Walker, Daniel W. Kulp, David B. Weiner
iScience. 2020; 23(8): 101399
[Pubmed]  [Google Scholar] [DOI]
93 COVID-19 Vaccines: A Race Against Time in the Middle of Death and Devastation!
Mohammad S. Khuroo, Mohammad Khuroo, Mehnaaz S. Khuroo, Ahmad A. Sofi, Naira S. Khuroo
Journal of Clinical and Experimental Hepatology. 2020; 10(6): 610
[Pubmed]  [Google Scholar] [DOI]
94 Lymphatic targeting by albumin-hitchhiking: Applications and optimisation
Mohammad Abdallah, Olivia O. Müllertz, Ian K. Styles, Alexander Mörsdorf, John F. Quinn, Michael R. Whittaker, Natalie L. Trevaskis
Journal of Controlled Release. 2020; 327: 117
[Pubmed]  [Google Scholar] [DOI]
95 Effects of MS disease-modifying therapies on responses to vaccinations: A review.
John Robert Ciotti, Manouela V. Valtcheva, Anne Haney Cross
Multiple Sclerosis and Related Disorders. 2020; 45: 102439
[Pubmed]  [Google Scholar] [DOI]
96 Fabrication and Characterization of Tumor Nano-Lysate as a Preventative Vaccine for Breast Cancer
Jenna A. Dombroski, Nidhi Jyotsana, Davis W. Crews, Zhenjiang Zhang, Michael R. King
Langmuir. 2020; 36(23): 6531
[Pubmed]  [Google Scholar] [DOI]
97 Convalescent plasma therapy: a promising coronavirus disease 2019 treatment strategy
Ravikant Piyush, Keshav Rajarshi, Rajni Khan, Shashikant Ray
Open Biology. 2020; 10(9): 200174
[Pubmed]  [Google Scholar] [DOI]
98 A COVID-19 vaccine—dare to dream
Alison Phillis
British Journal of Community Nursing. 2020; 25(12): 2
[Pubmed]  [Google Scholar] [DOI]
99 Vi-Vaccinations Induce Heterogeneous Plasma Cell Responses That Associate With Protection From Typhoid Fever
Deborah L. Cross, Marije K. Verheul, Michael D. Leipold, Gerlinde Obermoser, Celina Jin, Elizabeth Jones, Joshua S. Starr, Irina Mohorianu, Christoph J. Blohmke, Holden T. Maecker, Giorgio Napolitani, Jennifer Hill, Andrew J. Pollard
Frontiers in Immunology. 2020; 11
[Pubmed]  [Google Scholar] [DOI]
100 Emerging Concepts and Technologies in Vaccine Development
Morgan Brisse, Sophia M. Vrba, Natalie Kirk, Yuying Liang, Hinh Ly
Frontiers in Immunology. 2020; 11
[Pubmed]  [Google Scholar] [DOI]
101 Designing the Next Generation of Vaccines: Relevance for Future Pandemics
Jorge Domínguez-Andrés, Reinout van Crevel, Maziar Divangahi, Mihai G. Netea, Vinayaka R. Prasad
mBio. 2020; 11(6)
[Pubmed]  [Google Scholar] [DOI]
102 Toll-like receptors as a therapeutic target in cancer, infections and inflammatory diseases
Lizdany Flórez-Álvarez, Lanie Ruiz-Perez, Natalia Taborda, Juan C Hernandez
Immunotherapy. 2020; 12(5): 311
[Pubmed]  [Google Scholar] [DOI]
103

Convalescent Plasma Therapy for Management of COVID-19: Perspectives and Deployment in the Current Global Pandemic

Nandeeta Samad, Temitayo Eniola Sodunke, Hasan Al Banna, Ashmita Sapkota, Aneeka Nawar Fatema, Katia Iskandar, Dilshad Jahan, Timothy Craig Hardcastle, Tanzina Nusrat, Tajkera Sultana Chowdhury, Mainul Haque
Risk Management and Healthcare Policy. 2020; Volume 13: 2707
[Pubmed]  [Google Scholar] [DOI]
104 Herd immunization with childhood vaccination may provide protection against COVID-19
Yongqiang Yu
Acta Microbiologica et Immunologica Hungarica. 2020; 67(3): 198
[Pubmed]  [Google Scholar] [DOI]
105 Antimicrobial Resistance: A Tale of Nasty Enemies and Powerful Weapons
Fabiola Vacca, Dario Cardamone, Marco Troisi, Claudia Sala, Rino Rappuoli
Frontiers for Young Minds. 2020; 8
[Pubmed]  [Google Scholar] [DOI]
106 Perspectives in Peptide-Based Vaccination Strategies for Syndrome Coronavirus 2 Pandemic
Concetta Di Natale, Sara La Manna, Ilaria De Benedictis, Paola Brandi, Daniela Marasco
Frontiers in Pharmacology. 2020; 11
[Pubmed]  [Google Scholar] [DOI]
107 Vaccination in Atherosclerosis
Felix Sebastian Nettersheim, Lauren De Vore, Holger Winkels
Cells. 2020; 9(12): 2560
[Pubmed]  [Google Scholar] [DOI]
108 Narrative Review on Health-EDRM Primary Prevention Measures for Vector-Borne Diseases
Emily Chan, Tiffany Sham, Tayyab Shahzada, Caroline Dubois, Zhe Huang, Sida Liu, Kevin Hung, Shelly Tse, Kin Kwok, Pui-Hong Chung, Ryoma Kayano, Rajib Shaw
International Journal of Environmental Research and Public Health. 2020; 17(16): 5981
[Pubmed]  [Google Scholar] [DOI]
109 Clinician's Perspective on the Use of Hepatitis A Vaccine in Indian Children
Rishi Jain, Chetan Trivedi, Sanjay Marathe, Nishchal Bhat, Archana Karadkhele, Gaurav Puppalwar
Pediatric Infectious Disease. 2020; 1(4): 148
[Pubmed]  [Google Scholar] [DOI]
110 Alterations in the Human Plasma Lipidome in Response to Tularemia Vaccination
Kristal M. Maner-Smith, Johannes B. Goll, Manoj Khadka, Travis L. Jensen, Jennifer K. Colucci, Casey E. Gelber, Carolyn J. Albert, Steven E. Bosinger, Jacob D. Franke, Muktha Natrajan, Nadine Rouphael, Robert A. Johnson, Patrick Sanz, Evan J. Anderson, Daniel F. Hoft, Mark J. Mulligan, David A. Ford, Eric A. Ortlund
Vaccines. 2020; 8(3): 414
[Pubmed]  [Google Scholar] [DOI]
111 Immune Response to Vaccination in Patients with Psoriasis Treated with Systemic Therapies
Andrea Chiricozzi, Paolo Gisondi, Francesco Bellinato, Giampiero Girolomoni
Vaccines. 2020; 8(4): 769
[Pubmed]  [Google Scholar] [DOI]
112 High antibody titres induced by protein subunit vaccines using Mycobacterium ulcerans antigens Hsp18 and MUL_3720 with a TLR-2 agonist fail to protect against Buruli ulcer in mice
Kirstie M. Mangas, Nicholas J. Tobias, Estelle Marion, Jérémie Babonneau, Laurent Marsollier, Jessica L. Porter, Sacha J. Pidot, Chinn Yi Wong, David C. Jackson, Brendon Y. Chua, Timothy P. Stinear
PeerJ. 2020; 8: e9659
[Pubmed]  [Google Scholar] [DOI]
113 Impact of Microbiota: A Paradigm for Evolving Herd Immunity against Viral Diseases
Asha Shelly, Priya Gupta, Rahul Ahuja, Sudeepa Srichandan, Jairam Meena, Tanmay Majumdar
Viruses. 2020; 12(10): 1150
[Pubmed]  [Google Scholar] [DOI]
114 In-silico structural modeling and epitope prediction of highly conserved Plasmodium falciparum protein AMR1
Bijara Devi Sanasam, Sanjeev Kumar
Molecular Immunology. 2019; 116: 131
[Pubmed]  [Google Scholar] [DOI]
115 Current trends in targeted therapy for drug-resistant infections
Leila Rahbarnia, Safar Farajnia, Behrooz Naghili, Vahideh Ahmadzadeh, Kamal Veisi, Roghayyeh Baghban, Sayna Toraby
Applied Microbiology and Biotechnology. 2019; 103(20): 8301
[Pubmed]  [Google Scholar] [DOI]
116 Lectins as mitosis stimulating factors: Briefly reviewed
Elba V.M.M. Carvalho, Weslley F. Oliveira, Luana C.B.B. Coelho, Maria T.S. Correia
Life Sciences. 2018; 207: 152
[Pubmed]  [Google Scholar] [DOI]
117 Measuring autophagy level along with vaccine reactive IFN-?+CD4+ Th1 cells may be a promising approach to understand effi cacy of anti TB vaccine(s)
Parkash Om
Journal of Vaccines and Immunology. 2018; : 001
[Pubmed]  [Google Scholar] [DOI]
118 Effects of different cytokines on immune responses of rainbow trout in a virus DNA vaccination model
Yongsheng Cao, Qiya Zhang, Liming Xu, Shaowu Li, Di Wang, Jingzhuang Zhao, Hongbai Liu, Jian Feng, Tongyan Lu
Oncotarget. 2017; 8(68): 112222
[Pubmed]  [Google Scholar] [DOI]
119 The ongoing evolution of antibody-based treatments for Ebola virus infection
Emelissa J Mendoza, Trina Racine, Gary P Kobinger
Immunotherapy. 2017; 9(5): 435
[Pubmed]  [Google Scholar] [DOI]
120 Vaccinations in children on immunosuppressive medications for renal disease
Sushmita Banerjee, Pathum Vindana Dissanayake, Asiri Samantha Abeyagunawardena
Pediatric Nephrology. 2016; 31(9): 1437
[Pubmed]  [Google Scholar] [DOI]
121 Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response
Katharina M. Uhlig, Stefan Schülke, Vivian A. M. Scheuplein, Anna H. Malczyk, Johannes Reusch, Stefanie Kugelmann, Anke Muth, Vivian Koch, Stefan Hutzler, Bianca S. Bodmer, Axel Schambach, Christian J. Buchholz, Zoe Waibler, Stephan Scheurer, Michael D. Mühlebach, F. Kirchhoff
Journal of Virology. 2015; 89(17): 9044
[Pubmed]  [Google Scholar] [DOI]
122 Scrutinizing MHC-I Binding Peptides and Their Limits of Variation
Koch, C.P. and Perna, A.M. and Pillong, M. and Todoroff, N.K. and Wrede, P. and Folkers, G. and Hiss, J.A. and Schneider, G.
PLoS Computational Biology. 2013; 9(6)
[Pubmed]  [Google Scholar]
123 Immunization update: A 2011 retrospective on product changes and new recommendations
Phillips, K. and Alves, V.
Formulary. 2012; 47(2): 58-74
[Pubmed]  [Google Scholar]

 

Read this article
Sitemap | What's New | Feedback | Copyright and Disclaimer | Privacy Notice | Contact Us
© 2008 Journal of Global Infectious Diseases | Published by Wolters Kluwer - Medknow
Online since 10th December, 2008